2 Greenwich Office Park
Suite 210
Greenwich, CT 06831
203 863-0003
77 Lafayette Place
Suite 302
Greenwich, CT 06830
203 863-0003
21 Reade Place
Suite 2100
Poughkeepsie, NY 12601
203 863-0003
© 2024 The Plastic & Reconstructive Surgery Group - All Rights Reserved - Featured Realself Breast Reconstruction Expert - Terms of Use - Sitemap
News
Anaplastic Large Cell Lymphoma In Women with Breast Implants: Preliminary FDA Findings & Analyses
Posted Date: January 26, 2011
Reports in the scientific community have suggested a possible association between anaplastic large cell lymphoma (ALCL) and breast implants.
Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses
Executive Summary
Reports in the scientific community have suggested a possible association between anaplastic large cell lymphoma (ALCL) and breast implants. In its January 2011 report, the FDA summarizes the scientific data the Agency used to assess the possible association. It represents the FDA’s current understanding, based on the published scientific literature on ALCL in women with breast implants and information gathered through the FDA’s contact with other regulatory authorities, scientific experts, and breast implant manufacturers. The document includes the FDA’s analyses of the data and steps it plans to take to better understand and characterize the possible association.
The report, Anaplastic Large Cell Lymphoma (ALCL) In Women with Breast Implants: Preliminary FDA Findings and Analyses, is published on the FDA website